Urine Monocyte Chemoattractant Protein-1 and Lupus Nephritis Disease Activity: Preliminary Report of a Prospective Longitudinal Study

Autoimmune Diseases

Volumn 2015, Issue , 2015, Pages

  Alharazy, Sabah ^a   Kong, Norella C T ^a   Mohd, Marlyn ^b   Shah, Shamsul A ^b   Ba'In, Arbaiyah ^a   Abdul Gafor, Abdul Halim ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; LONGITUDINAL STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; PROTEINURIA; RELAPSE; REMISSION; REPEAT PROCEDURE; SLEDAI;

EID: 84938150128     PISSN: 20900422     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2015/962046     Document Type: Article

References (43)

1. S. M. Korbet, E. J. Lewis, M. M. Schwartz et al. , "Factors predictiveof outcome in severe lupus nephritis, " The AmericanJournal of Kidney Diseases, vol. 35, no. 5, pp. 904-914, 2000.
2. J. Reyes-Thomas, I. Blanco, and C. Putterman, "Urinarybiomarkers in lupus nephritis, " Clinical Reviews in Allergy &Immunology, vol. 40, no. 3, pp. 138-150, 2011.
3. A. Chaib, N. Mellilo, S. R. Sangle et al. , "Antiphospholipidantibodies and increased bleeding complications followingrenal biopsy: a single centre study, " Arthritis&Rheumatism, vol. 56, abstract supplement, 2007.
4. J. E. Balow, "Clinical presentation and monitoring of lupusnephritis, " Lupus, vol. 14, no. 1, pp. 25-30, 2005.
5. A. Matrat, C. Veysseyre-Balter, P. Trolliet et al. , "Simultaneousdetection of anti-C1q and anti-double stranded DNA autoantibodiesin lupus nephritis: predictive value for renal flares, "Lupus, vol. 20, no. 1, pp. 28-34, 2011.
6. E. Tarabra, S. Giunti, F. Barutta et al. , "Effect of the monocytechemoattractant protein-1/CC chemokine receptor 2 system onnephrin expression in streptozotocin-treated mice and humancultured podocytes, " Diabetes, vol. 58, no. 9, pp. 2109-2118, 2009.
7. S. D. Marks, S. J. Williams, K. Tullus, and N. J. Sebire, "Glomerularexpression of monocyte chemoattractant protein-1 ispredictive of poor renal prognosis in paediatric lupus nephritis, "Nephrology Dialysis Transplantation, vol. 23, no. 11, pp. 3521-3526, 2008.
8. B. H. Rovin, H. Song, D. J. Birmingham, L. A. Hebert, C. Y. Yu, and H. N. Nagaraja, "Urine chemokines as biomarkers ofhuman systemic lupus erythematosus activity, " Journal of theAmerican Society ofNephrology, vol. 16, no. 2, pp. 467-473, 2005.
9. S. Tian, J. Li, L. Wang et al. , "Urinary levels of RANTES andM-CSF are predictors of lupus nephritis flare, " InflammationResearch, vol. 56, no. 7, pp. 304-310, 2007.
10. A. N. Kiani, K. Johnson, C. Chen et al. , "Urine osteoprotegerinand monocyte chemoattractant protein-1 in lupus nephritis, "Journal of Rheumatology, vol. 36, no. 10, pp. 2224-2230, 2009.
11. S. Alharazy, N. C. T. Kong, M. Mohd, S. A. Shah, A. Baín, andA. H. AbdulGafor, "Urinarymonocyte chemoattractant proteinand lupus nephritis activity, " Journal of Clinical & CellularImmunology, vol. 5, article 187, 2014.
12. S. M. Alharazy, N. C. T. Kong, M. Mohd, S. A. Shah, A. H. Abdul-Gafor, and A. Baín, "The role of urinary neutrophilgelatinase-associated lipocalin in lupus nephritis, " Clinica ChimicaActa, vol. 425, pp. 163-168, 2013.
13. M. C. Hochberg, "Updating the American College of Rheumatologyrevised criteria for the classification of systemic lupuserythematosus, " Arthritis & Rheumatism, vol. 40, no. 9, p. 1725, 1997.
14. N. C. T. Kong, "Pulse Cyclophosphamide versus added dual filtrationplasmapheresis (DFPP) therapy for severe lupus nephritis, "UKM Research Clinical Trial Code FF-324-2011, 2010.
15. D. D. Gladman, D. Ibañez, and M. B. Urowltz, "Systemiclupus erythematosus disease activity index 2000, " Journal ofRheumatology, vol. 29, no. 2, pp. 288-291, 2002.
16. K. Yamaji, Y.-J. Kim, H. Tsuda, and Y. Takasaki, "Long-termclinical outcomes of synchronized therapy with plasmapheresisand intravenous cyclophosphamide pulse therapy in the treatmentof steroid-resistant lupus nephritis, "Therapeutic Apheresisand Dialysis, vol. 12, no. 4, pp. 298-305, 2008.
17. G. Ruiz-Irastorza, G. Espinosa, M. A. Frutos et al. , "Diagnosisand treatment of Lupus nephritis: consensus document fromthe systemic auto-immune disease group (GEAS) of the Spanishsociety of internal medicine (SEMI) and the Spanish Society ofNephrology (S. E. N. ), " Nefrologia, vol. 32, supplement 1, pp. 1-45, 2012.
18. C. Bombardier, D. D. Gladman, M. B. Urowitz et al. , "Derivationof the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE, " Arthritis &Rheumatism, vol. 35, no. 6, pp. 630-640, 1992.
19. W. J. Youden, "Index for rating diagnostic tests, " Cancer, vol. 3, no. 1, pp. 32-35, 1950.
20. R. G. Singh, S. S. Rathore, S. K. Behura, and N. K. Singh, "UrinaryMCP-1 as diagnostic and prognostic marker in patientswith lupus nephritis flare, " Lupus, vol. 21, no. 11, pp. 1214-1218, 2012.
21. S. Torabinejad, R. Mardani, Z. Habibagahi et al. , "Urinary monocytechemotactic protein-1 and transforming growth factor-in systemic lupus erythematosus, " Indian Journal of Nephrology, vol. 22, no. 1, pp. 5-12, 2012.
22. M. Tucci, E. V. Barnes, E. S. Sobel et al. , "Strong association ofa functional polymorphism in the monocyte chemoattractantprotein 1 promoter gene with lupus nephritis, " Arthritis &Rheumatism, vol. 50, no. 6, pp. 1842-1849, 2004.
23. R. W.-Y. Chan, F. M.-M. Lai, E. K.-M. Li et al. , "Expressionof chemokine and fibrosing factor messenger RNA in theurinary sediment of patients with lupus nephritis, " Arthritis &Rheumatism, vol. 50, no. 9, pp. 2882-2890, 2004.
24. A. Alzawawy, M. Zohary, M. Ablordiny, and M. Eldalie, "Estimation of monocyte-chemoattractantprotein-1 (Mcp-1)level in patients with lupus nephritis, " International Journal ofRheumatic Diseases, vol. 12, no. 4, pp. 311-318, 2009.
25. L. Watson, K. Tullus, C. Pilkington et al. , "Urine biomarkers formonitoring juvenile lupus nephritis: a prospective longitudinalstudy, " Pediatric Nephrology, vol. 29, no. 3, pp. 397-405, 2014.
26. M. Noris, S. Bernasconi, F. Casiraghi et al. , "Monocyte chemoattractantprotein-1 is excreted in excessive amounts in the urineof patients with lupus nephritis, " Laboratory Investigation, vol. 73, no. 6, pp. 804-809, 1995.
27. A. El-Shehaby, H. Darweesh, M. El-Khatib et al. , "Correlationsof urinary biomarkers, TNF-like weak inducer of apoptosis(TWEAK), osteoprotegerin (OPG), monocyte chemoattractantprotein-1 (MCP-1), and IL-8 with lupus nephritis, " Journal ofClinical Immunology, vol. 31, no. 5, pp. 848-856, 2011.
28. R. F. Rosa, K. Takei, N. C. Araújo, S. M. A. Loduca, J. C. M. Szajubok, and W. H. Chahade, "Monocyte chemoattractant-1as a urinary biomarker for the diagnosis of activity of lupusnephritis in Brazilian patients, " Journal of Rheumatology, vol. 39, no. 10, pp. 1948-1954, 2012.
29. G. H. Tesch, S. Maifert, A. Schwarting, B. J. Rollins, andV. R. Kelley, "Monocyte chemoattractant protein 1-dependentleukocytic infiltrates are responsible for autoimmune disease inMRL-Fas(lpr) mice, " Journal of Experimental Medicine, vol. 190, no. 12, pp. 1813-1824, 1999.
30. H. L. Kim, D.-S. Lee, S. H. Yang et al. , "The polymorphism ofmonocyte chemoattractant protein-1 is associatedwith the renaldisease of SLE, " American Journal of KidneyDiseases, vol. 40, no. 6, pp. 1146-1152, 2002.
31. H. Susianti, V. M. Iriane, S. Dharmanata et al. , "Analysis ofurinary TGF-1, MCP-1, NGAL, and IL-17 as biomarkers forlupus nephritis, " Pathophysiology, vol. 22, no. 1, pp. 65-71, 2015.
32. B. H. Rovin and X. Zhang, "Biomarkers for lupus nephritis:the quest continues, " Clinical Journal of the American Society ofNephrology, vol. 4, no. 11, pp. 1858-1865, 2009.
33. Z. Adhya, S. Borozdenkova, and M. Y. Karim, "The role of cytokinesas biomarkers in systemic lupus erythematosus and lupusnephritis, " Nephrology, Dialysis, Transplantation, vol. 26, no. 10, pp. 3273-3280, 2011.
34. S. Alharazy, Urinary neutrophil gelatinase-associated lipocalinand monocyte chemoattractant protein-1 as biomarkers of renaldisease activity in lupus nephritis [Ph. D. thesis], 2015, UKMResearch Clinical Trial Code (FF-446-2011).
35. R. P. Horgan and L. C. Kenny, "SAC review 'Omic' technologies:genomics, transcriptomics, proteomics and metabolomics, " TheObstetrician & Gynaecologist, vol. 13, pp. 189-195, 2011.
36. J. C. He, P. Y. Chuang, A. Ma'Ayan, and R. Iyengar, "Systemsbiology of kidney diseases, " Kidney International, vol. 81, no. 1, pp. 22-39, 2012.
37. C. C. Berthier, M. Kretzler, and A. Davidson, "From thelarge scale expression analysis of lupus nephritis to targetedmolecular medicine, " Journal of Data Mining in Genomics &Proteomics, vol. 3, no. 3, 2012.
38. K. E. C. Meyers, P. D. Thomson, and H. Weiland, "Noncompliancein children and adolescents after renal transplantation, "Transplantation, vol. 62, no. 2, pp. 186-189, 1996.
39. K. Denhaerynck, F. Dobbels, I. Cleemput et al. , "Prevalence, consequences, and determinants of nonadherence in adult renaltransplant patients: a literature review, " Transplant International, vol. 18, no. 10, pp. 1121-1133, 2005.
40. F. Dobbels, A. Hames, I. Aujoulat, N. Heaton, and M. Samyn, "Should we retransplant a patient who is non-adherent A literaturereview and critical reflection, " Pediatric Transplantation, vol. 16, no. 1, pp. 4-11, 2012.
41. M. Adler, S. Chambers, C. Edwards, G. Neild, and D. Isenberg, "An assessment of renal failure in an SLE cohort with specialreference to ethnicity, over a 25-year period, " Rheumatology, vol. 45, no. 9, pp. 1144-1147, 2006.
42. N. Costedoat-Chalumeau, Z. Amoura, J.-S. Hulot et al. , "Verylow blood hydroxychloroquine concentration as an objectivemarker of poor adherence to treatment of systemic lupuserythematosus, " Annals of the Rheumatic Diseases, vol. 66, no. 6, pp. 821-824, 2007.
43. F. Rivera and S. Anaya, "Lupus nephritis flare in young patients:relapse or nonadherence to treatment" International Journal ofNephrology and Renovascular Disease, vol. 7, pp. 117-121, 2014.